Separating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190.
about
p38 MAPK Signaling in Osteoblast DifferentiationRegulation of cell-cell fusion by nanotopography.Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma.In vitro supplementation with the porcine plasma product, betaGRO®, stimulates activity of porcine fetal myoblasts and neonatal satellite cells in a divergent manner.Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy.
P2860
Separating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Separating myoblast differenti ...... MAP kinase inhibitor SB202190.
@ast
Separating myoblast differenti ...... MAP kinase inhibitor SB202190.
@en
type
label
Separating myoblast differenti ...... MAP kinase inhibitor SB202190.
@ast
Separating myoblast differenti ...... MAP kinase inhibitor SB202190.
@en
prefLabel
Separating myoblast differenti ...... MAP kinase inhibitor SB202190.
@ast
Separating myoblast differenti ...... MAP kinase inhibitor SB202190.
@en
P2093
P2860
P1476
Separating myoblast differenti ...... MAP kinase inhibitor SB202190.
@en
P2093
John E Klimek
Larry L David
Peter Rotwein
Sean M Gross
P2860
P304
P356
10.1152/AJPCELL.00184.2015
P577
2015-08-05T00:00:00Z